Salivary and serum nitric oxide synthase, macrophage inflammatory protein 1 alpha and macrophage migration inhibitory factor levels in periodontal disease

被引:0
|
作者
Oner, Fatma [1 ]
Onat, Faruk Cagri [2 ]
Karasu, Yerda Ozkan [2 ,3 ]
机构
[1] Bahcesehir Univ, Fac Dent Med, Dept Periodontol, Istanbul, Turkiye
[2] Ataturk Univ, Fac Dent & Med, Dept Periodontol, Erzurum, Turkiye
[3] Ataturk Univ, Fac Dent Med, Dept Periodontol, TR-25200 Yakutiye Erzurum, Turkiye
关键词
Gingivitis; iNOS; MIP-1; alpha; MIF; Periodontitis; PERI-IMPLANT DISEASES; 2017 WORLD WORKSHOP; CONSENSUS REPORT; MIP-1-ALPHA; EXPRESSION; BIOMARKERS; MIF; CLASSIFICATION; CONTRIBUTES; IMMUNITY;
D O I
10.1016/j.heliyon.2024.e25888
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Periodontal disease is multifactorial inflammatory disease involving both gingivitis and periodontitis. Inducible nitric oxide synthase (iNOS), macrophage inflammatory protein 1 alpha (MIP-1 alpha) and macrophage migration inhibitory factor (MIF) are mediators contributing to the progression of periodontal diseases with distinct functions. The aim of this study is to evaluate the local and systemic iNOS, MIP-1 alpha and MIF concentrations in patients having periodontal disease with different severities. Design: The study was conducted on 88 individuals equally divided into four groups; 1) Periodontally Healthy 2) Gingivitis 3) Stage I-II Periodontitis 4) Stage III-IV Periodontitis. Saliva and serum samples were obtained from each individual and then periodontal examinations were performed. Plaque and bleeding on probing indexes, probing depths and clinical attachment levels were measured on each tooth to determine the periodontal status. Concentrations of iNOS, MIP-1 alpha and MIF were measured with enzyme -linked immunosorbent assay. Results: Patients with stage I-II and stage III-IV periodontitis had more iNOS levels than periodontally healthy people in serum and saliva (p <= 0,001 for serum; p < 0,05 for saliva). Stage III-IV periodontitis group had significantly more serum-iNOS levels than that in gingivitis group (p = 0,005). When compared with periodontally healthy individuals, MIP-1 alpha levels in stage III-IV periodontitis patients were measured significantly more in saliva; (p = 0,016) but less in serum (p = 0,006) samples. More serum-MIF concentrations were observed in stage I-II periodontitis groups than that in periodontally healthy individuals (p < 0,05). Conclusion: Increased salivary and serum iNOS and serum-MIF levels in different stages of periodontitis suggest that these molecules might be involved in periodontal disease pathogenesis. Also, oral microenvironment may stimulate the enhanced MIP-1 alpha concentration in advanced periodontitis cases.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Molecular function of macrophage migration inhibitory factor and a novel therapy for inflammatory bowel disease
    Nishihira, Jun
    NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER, 2012, 1271 : 53 - 57
  • [42] Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease
    Donnelly, SC
    Bucala, R
    MOLECULAR MEDICINE TODAY, 1997, 3 (11): : 502 - 507
  • [43] Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Susceptibility to Inflammatory Coronary Heart Disease
    Ji, Kangting
    Wang, Xiaoyan
    Li, Ji
    Lu, Qin
    Wang, Guoqiang
    Xue, Yangjing
    Zhang, Suqin
    Qian, Lu
    Wu, Wenwu
    Zhu, Yongjin
    Wang, Luping
    Liao, Lianming
    Tang, Jifei
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [44] A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease
    Kithcart, Aaron P.
    Cox, Gina M.
    Sielecki, Thais
    Short, Abigail
    Pruitt, James
    Papenfuss, Tracey
    Shawler, Todd
    Gienapp, Ingrid
    Satoskar, Abhay R.
    Whitacre, Caroline C.
    FASEB JOURNAL, 2010, 24 (11): : 4459 - 4466
  • [45] SERUM LEVELS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND INTERLEUKIN-1 FAMILY CYTOKINES ARE ELEVATED IN SYSTEMIC SCLEROSIS
    Lin, E.
    Vincent, F.
    Harris, J.
    Kandane-Rathnayake, R.
    Ngian, G-S
    Sahhar, J.
    Morand, E.
    Lang, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 416 - 416
  • [46] SERUM LEVELS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND INTERLEUKIN-1 FAMILY CYTOKINES ARE ELEVATED IN SYSTEMIC SCLEROSIS
    Lin, E.
    Vincent, F.
    Harris, J.
    Kandane-Rathnayak, R.
    Ngian, G-S
    Sahhar, J.
    Morand, E.
    Lang, T.
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 34 - 34
  • [47] Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease
    Yuksel, Arif
    Bilgir, Ferda
    Bilgir, Oktay
    Calan, Mehmet
    Bozkaya, Giray
    CLINICS, 2015, 70 (03) : 169 - 172
  • [48] Elevated Serum Macrophage Migration Inhibitory Factor Levels in Post-operative Biliary Atresia
    Nattee, Papit
    Honsawek, Sittisak
    Chongsrisawat, Voranush
    Vejchapipat, Paisarn
    Thamboonlers, Apiradee
    Poovorawan, Yong
    ASIAN JOURNAL OF SURGERY, 2009, 32 (02) : 109 - 113
  • [49] Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjogren's syndrome
    Willeke, Peter
    Gaubitz, Markus
    Schotte, Heiko
    Maaser, Christian
    Domschke, Wolfram
    Schlueter, Bernhard
    Becker, Heidemarie
    ARTHRITIS RESEARCH & THERAPY, 2007, 9 (02)
  • [50] Serum and ascitic levels of macrophage migration inhibitory factor (MIF) are increased in severe acute pancreatitis
    Sakai, Y
    Masamune, A
    Satoh, A
    Yamagiwa, T
    Shimosegawa, T
    GASTROENTEROLOGY, 2001, 120 (05) : A469 - A469